What is Telprevir?

doctors prescribe an antivirus drug Telprevir in conjunction with peginterferon alpha and ribavirin for the treatment of hepatitis C (HCV) virus. HCV not only increases the likelihood of virus deactivation, but can also reduce the amount of time patients require treatment. The treatment regimen can cause anemia and usually causes symptoms similar to flu. Telprevir interacts with many prescribed medicines.

TELPREVIR is an antiviral protease treatment that disrupts the serine protease NS3/4A. This enzyme is responsible for maturity of protein and adhesion of proteins. When these processes are inhibited, the virus cannot replicate. The Hepatitis C Genotype 1 virus is the most common strain of the disease and is also the most resistant to treatment. HCV treatment does not completely exclude the virus from the body. However, drugs usually reduce the viral load to the point where the infection becomes undetectable.

Conventionrapy usually included a combined mode of peginterferon alpha and ribavirin taken for 24 to 48 weeks. Some patients have troubleE with adherence to treatment as prescribed due to the length of therapy. Other patients interrupt therapy due to side effects associated with drugs. Of the individuals who adhere to the prescribed therapy, the virus has been revived in one half.

Adding Telprevir to therapy mode has shown evidence of reduced viral loads anywhere from four to 12 weeks. The drastic degree and quality of improvement, which witnessed patients during studies, allowed doctors to shorten the time to be administered for the alpha and ribavirin peginterferon. The recommended dosage of Telprevir is 750 milligrams three times a day, up to 30 minutes after consumption of at least 20% fat. Optimal treatment requires the requirements of the iRes to take Telprevir for 12 weeks. Patients must continue with other prescribed medicines for another 12 to 36 weeks.

The side effects of Telprevir include nausea, vomiting and diarrhea in the range of rectal irritation. PoisonNotes can also develop anemia that is experienced as dizziness, shortness of breath and fatigue followed by generalized weakness. Hematological effects also include a reduced number of platelets and white blood cells, making patients more susceptible to infection. Patients who show blisters, lesions or rash on the skin or mouth should notify a doctor. Individuals should also report fever, swelling of the face and any redness of the eyes that resemble conjunctivitis.

Before the treatment of Telprevir, patients must publish all health conditions and current medicines. Pregnant women cannot undergo the therapy regime for possible intervention in normal cell reproduction and doctors strong people recommend that women use at least two forms of contraception during treatment. Antiviral drugs also interact with numerous drugs, including anti -infectious substances, cholesterol reducing agents and certain heart formulations.